Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Zamicastat is an inhibitor of dopamine β-hydroxylase (DβH).1 It increases levels of norepinephrine and decreases levels of dopamine in the hearts of aged spontaneously hypertensive rats (SHRs) when administered at a dose of 30 mg/kg per day. Zamicastat decreases diastolic and systolic blood pressure in the same model. It increases serum levels of erythropoietin (EPO), decreases the heart-to-body weight ratio, and increases survival in a mouse model of hypertension using aged rats fed a high-salt diet.2
WARNING This product is not for human or veterinary use.
1. Cardiometabolic and inflammatory benefits of sympathetic down-
2. Effects of zamicastat treatment in a genetic model of salt-